Literature DB >> 11899754

T lymphocyte activation--an inside overview.

M Aringer1.   

Abstract

Activated T lymphocytes play an important role in autoimmune disease. The process of T-cell activation is therefore of significant importance in understanding the pathogenesis of many rheumatic diseases. This process can be observed from outside the lymphocyte, but we have also gained increased understanding of many of the intracellular events of T-cell activation. This review tries to draw out the most important receptors, pathways, and transcription factors involved in the process.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11899754     DOI: 10.1046/j.1563-2571.2002.01044.x

Source DB:  PubMed          Journal:  Acta Med Austriaca        ISSN: 0303-8173


  5 in total

1.  Long term safety of etanercept in elderly subjects with rheumatic diseases.

Authors:  R Fleischmann; S W Baumgartner; M H Weisman; T Liu; B White; P Peloso
Journal:  Ann Rheum Dis       Date:  2005-09-08       Impact factor: 19.103

2.  Vitamin E protects against oxidative damage caused by formaldehyde in the liver and plasma of rats.

Authors:  Mukaddes Gulec; Ahmet Gurel; Ferah Armutcu
Journal:  Mol Cell Biochem       Date:  2006-08-26       Impact factor: 3.396

3.  Preferential feline immunodeficiency virus (FIV) infection of CD4+ CD25+ T-regulatory cells correlates both with surface expression of CXCR4 and activation of FIV long terminal repeat binding cellular transcriptional factors.

Authors:  Anjali Joshi; Himanshu Garg; Mary B Tompkins; Wayne A Tompkins
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

4.  Evaluation of clinical biomaterial surface effects on T lymphocyte activation.

Authors:  Analiz Rodriguez; James M Anderson
Journal:  J Biomed Mater Res A       Date:  2010-01       Impact factor: 4.396

5.  Central nervous system demyelination associated with etanercept in a 51 years old woman.

Authors:  Wanis H Ibrahim; Mohammed Hammoudah; Naveed Akhtar; Hassan Al-Hail; Dirk Deleu
Journal:  Libyan J Med       Date:  2007-06-01       Impact factor: 1.657

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.